Wassilis S.C. Bruins

T-Cell Characteristics Impact Response and Resistance to T-Cell–Redirecting Bispecific Antibodies in Multiple Myeloma

Christie P.M. Verkleij, Chloe O’Neill, Marloes E.C. Broekmans et al. · Clinical Cancer Research · 2024 · 43 citations

NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma

Christie P.M. Verkleij, Kristine A. Frerichs, Marloes E.C. Broekmans et al. · HemaSphere · 2023 · 32 citations · Full text

Hypermethylated <i>RASSF1A</i> as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma

Lieke M. J. van Zogchel, Esther M. van Wezel, Jalenka van Wijk et al. · JCO Precision Oncology · 2020 · 23 citations · Full text

TAK-169, a Novel Recombinant Immunotoxin Specific for CD38, Induces Powerful Preclinical Activity Against Patient-Derived Multiple Myeloma Cells

Wassilis S.C. Bruins, Wenrou Zheng, Jack P. Higgins et al. · Blood · 2020 · 13 citations

Preclinical Activity of Allogeneic CS1-Specific CAR T-Cells (UCARTCS1) in Multiple Myeloma

Charlotte L.B.M. Korst, Wassilis S.C. Bruins, Meliha Cosovic et al. · Blood · 2022 · 11 citations